Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 108 contracts
Samples: Credit Agreement (Sonendo, Inc.), Services Agreement, Voting Agreement (Sonendo, Inc.)
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Articles or Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 88 contracts
Samples: Loan and Security Agreement (Contineum Therapeutics, Inc.), Warrant to Purchase Stock (Singular Genomics Systems, Inc.), Purchase Stock (Root Stockholdings, Inc.)
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the The number of shares of common stock issuable upon conversion of the Shares Shares, shall be subject to anti-dilution adjustment adjustment, from time to time in the manner set forth in the Company’s Certificate of Incorporation as if with respect to issuance of securities for a price lower than certain prices specified in the Shares were issued and outstanding on and as Certificate of the date of any such required adjustmentIncorporation.
Appears in 10 contracts
Samples: Convertible Promissory Note and Warrant Purchase Agreement (VG Life Sciences Inc.), Convertible Promissory Note and Warrant Purchase Agreement (VG Life Sciences Inc.), And Warrant Purchase Agreement (VG Life Sciences Inc.)
Adjustments for Diluting Issuances. Without duplication of Except as would duplicate any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 8 contracts
Samples: Stockholder Option and Support Agreement (Constellation Pharmaceuticals Inc), Stockholder Option and Support Agreement (Constellation Pharmaceuticals Inc), Stockholder Option and Support Agreement (Constellation Pharmaceuticals Inc)
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation Charter as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 7 contracts
Samples: Loan and Security Agreement (Relypsa Inc), Loan and Security Agreement (Relypsa Inc), Voting Agreement (Relypsa Inc)
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, for so long as this Warrant is exercisable for shares of Preferred Stock, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Articles or Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 6 contracts
Samples: Venus Concept Inc., Restoration Robotics Inc, Restoration Robotics Inc
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner manner, if any, then set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 6 contracts
Samples: Vitae Pharmaceuticals, Inc, Vitae Pharmaceuticals, Inc, Vitae Pharmaceuticals, Inc
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section Article 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment adjustment; from time to time in the manner set forth in the Company’s Certificate of Incorporation (as amended from time to time) as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 5 contracts
Samples: iRhythm Technologies, Inc., iRhythm Technologies, Inc., iRhythm Technologies, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 5 contracts
Samples: ThredUp Inc., ThredUp Inc., aTYR PHARMA INC
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of ordinary shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate Memorandum and Articles of Incorporation Association as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 4 contracts
Samples: Lombard Medical, Inc., Lombard Medical, Inc., Lombard Medical, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment applicable to the Class from time to time in the manner set forth in the Company’s Certificate of Incorporation Restated Certificate, as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 4 contracts
Samples: Poseida Therapeutics, Inc., Poseida Therapeutics, Inc., Poseida Therapeutics, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Articles or Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.. 2.5
Appears in 4 contracts
Samples: CVRx, Inc., CVRx, Inc., CVRx, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in made pursuant to this Section Article 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.required
Appears in 4 contracts
Samples: Clarus Therapeutics Inc, Clarus Therapeutics Inc, Clarus Therapeutics Inc
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section Article 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 3 contracts
Samples: 1Life Healthcare Inc, 1Life Healthcare Inc, eASIC Corp
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in accordance with the manner set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 3 contracts
Samples: Kaleido Biosciences, Inc., Kaleido Biosciences, Inc., Evelo Biosciences, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Articles or Restated Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 3 contracts
Samples: Sumo Logic, Inc., Sumo Logic, Inc., Sumo Logic, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation Charter as if the Shares were issued and outstanding on and as of the date of any such required adjustmentadjustment (and subject to waiver by the required holders of the outstanding shares of the Class in accordance with the Charter).
Appears in 3 contracts
Samples: 908 Devices Inc., 908 Devices Inc., 908 Devices Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 3 contracts
Samples: Loan and Security Agreement (Kala Pharmaceuticals, Inc.), Loan and Security Agreement (Kala Pharmaceuticals, Inc.), Loan and Security Agreement (Kala Pharmaceuticals, Inc.)
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section Article 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment adjustment, from time to time in the manner set forth in the Company’s Certificate of Incorporation (as amended from time to time) as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 3 contracts
Samples: iRhythm Technologies, Inc., iRhythm Technologies, Inc., iRhythm Technologies, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.Articles or
Appears in 2 contracts
Samples: Purchase Stock (Root, Inc.), Purchase Stock (Root Stockholdings, Inc.)
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the The number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment adjustment, from time to time in the manner set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 2 contracts
Samples: Airxpanders Inc, Airxpanders Inc
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Restated Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 2 contracts
Samples: Investor Rights Agreement (Blueprint Medicines Corp), Blueprint Medicines Corp
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner for such securities as set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 2 contracts
Samples: Nalu Medical, Inc., Nalu Medical, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock Common Stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner as may be set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 2 contracts
Samples: Warrant Agreement (Leo Holdings III Corp.), Warrant Agreement (Local Bounti Corporation/De)
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 23, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation Incorporation, as amended and in effect from time to time, as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 2 contracts
Samples: Purchase Common Stock (Impel Neuropharma Inc), Purchase Common Stock (Impel Neuropharma Inc)
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment applicable to the Class from time to time in the manner set forth in the Company’s Certificate of Incorporation Incorporation, as amended and/or restated from time to time, as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 2 contracts
Samples: Poseida Therapeutics, Inc., Poseida Therapeutics, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the The number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment adjustment, from time to time in the manner set forth in the Company’s Articles or Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.adjustment The provisions set forth for the Shares in the Company’s Articles or Certificate (as applicable) of Incorporation relating to the above in effect as of the Issue Date may not be amended, modified or waived, without the prior written
Appears in 2 contracts
Samples: Tremor Video Inc., Tremor Video Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the The number of shares of common stock issuable upon conversion of the Shares Shares, shall be subject to anti-dilution adjustment adjustment, from time to time in the manner set forth in the Company’s 's Certificate of Incorporation as if with respect to issuance of securities for a price lower than certain prices specified in the Shares were issued and outstanding on and as Certificate of the date of any such required adjustmentIncorporation.
Appears in 2 contracts
Samples: And Warrant Purchase Agreement (VG Life Sciences, Inc.), Convertible Promissory Note And (VG Life Sciences, Inc.)
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s 's Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.. 2.5
Appears in 2 contracts
Samples: CVRx, Inc., CVRx, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of ordinary shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation Constitution as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 2 contracts
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the The number of shares of common stock issuable upon conversion of the Shares Shares, shall be subject to anti-dilution adjustment adjustment, from time to time in the manner set forth in the Company’s Articles or Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 2 contracts
Samples: Apptio Inc, Apptio Inc
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock Common Stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 2 contracts
Samples: Fitbit Inc, Fitbit Inc
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation (including giving effect to any waiver of such required adjustment effected in accordance with the terms of the Certificate of Incorporation) as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 2 contracts
Samples: Sigilon Therapeutics, Inc., Sigilon Therapeutics, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Articles or Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustmentadjustment and to the extent applicable to other outstanding shares of the Class.
Appears in 2 contracts
Samples: Infinity Oil & Gas Co, Infinity Oil & Gas Co
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock Common Stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Third Amended and Restated Certificate of Incorporation Incorporation, as further amended or amended and restated from time to time (the “Certificate of Incorporation”), as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 2 contracts
Samples: Metacrine, Inc., Metacrine, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Articles or Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment, if any.
Appears in 1 contract
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the The number of shares of common stock issuable upon conversion of the Shares Shares, shall be subject to anti-dilution adjustment adjustment, from time to time in the manner set forth in accordance with the Company’s 's Second Amended and Restated Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustmentIncorporation.
Appears in 1 contract
Samples: Immunicon Corp
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation (as then in effect) as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 1 contract
Samples: Neuronetics, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment. For the avoidance of doubt, any waiver by the requisite percentage of holders of capital stock of the Company with respect to any such anti-dilution provisions pursuant to the Certificate of Incorporation shall also apply to Holder.
Appears in 1 contract
Samples: Vividion Therapeutics, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion the exercise of the Shares this Warrant shall be subject to any anti-dilution adjustment generally applicable to the Class from time to time in the manner set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 1 contract
Samples: Mabvax Therapeutics Holdings, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation (including giving effect to any waiver of such required adjustment effected in accordance with the terms of the Certificate of Incorporation) as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 1 contract
Samples: Prometheus Biosciences, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment applicable to the Class from time to time in the manner set forth in the Company’s Restated Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 1 contract
Samples: Millendo Therapeutics, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment applicable to the Class from time to time in the manner set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 1 contract
Samples: Aviragen Therapeutics, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 1 contract
Samples: Principia Biopharma Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to the same anti-dilution adjustment adjustments, if any, made to the outstanding shares of the Class from time to time in the manner set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 1 contract
Samples: AVROBIO, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation Incorporation, as amended and/or restated and in effect from time to time (the “Charter”) as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 1 contract
Samples: Alto Neuroscience, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 1 contract
Samples: Mohawk Group Holdings, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation COI as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 1 contract
Samples: Alx Oncology Holdings Inc
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s 's Certificate of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 1 contract
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Amended and Restated Certificate of Incorporation as in effect on the Issue Date, as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 1 contract
Samples: Auspex Pharmaceuticals, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate of Incorporation Incorporation, as then in effect, as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 1 contract
Samples: Silverback Therapeutics, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate certificate of Incorporation incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 1 contract
Samples: Five9, Inc.
Adjustments for Diluting Issuances. Without duplication of any adjustment otherwise provided for in this Section 2, the number of shares of common stock issuable upon conversion of the Shares shall be subject to anti-dilution adjustment from time to time in the manner set forth in the Company’s Certificate Articles of Incorporation as if the Shares were issued and outstanding on and as of the date of any such required adjustment.
Appears in 1 contract
Samples: Invuity, Inc.